These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Improved Locomotor Recovery in a Rat Model of Spinal Cord Injury by BioLuminescent-OptoGenetic (BL-OG) Stimulation with an Enhanced Luminopsin. Ikefuama EC; Kendziorski GE; Anderson K; Shafau L; Prakash M; Hochgeschwender U; Petersen ED Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361784 [TBL] [Abstract][Full Text] [Related]
5. Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation. Berglund K; Clissold K; Li HE; Wen L; Park SY; Gleixner J; Klein ME; Lu D; Barter JW; Rossi MA; Augustine GJ; Yin HH; Hochgeschwender U Proc Natl Acad Sci U S A; 2016 Jan; 113(3):E358-67. PubMed ID: 26733686 [TBL] [Abstract][Full Text] [Related]
6. The BioLuminescent-OptoGenetic in vivo response to coelenterazine is proportional, sensitive, and specific in neocortex. Gomez-Ramirez M; More AI; Friedman NG; Hochgeschwender U; Moore CI J Neurosci Res; 2020 Mar; 98(3):471-480. PubMed ID: 31544973 [TBL] [Abstract][Full Text] [Related]
8. Defining parameters of specificity for bioluminescent optogenetic activation of neurons using in vitro multi electrode arrays (MEA). Prakash M; Medendorp WE; Hochgeschwender U J Neurosci Res; 2020 Mar; 98(3):437-447. PubMed ID: 30152529 [TBL] [Abstract][Full Text] [Related]
9. Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo. Crespo EL; Bjorefeldt A; Prakash M; Hochgeschwender U J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424228 [TBL] [Abstract][Full Text] [Related]
10. Combined Optogenetic and Chemogenetic Control of Neurons. Berglund K; Tung JK; Higashikubo B; Gross RE; Moore CI; Hochgeschwender U Methods Mol Biol; 2016; 1408():207-25. PubMed ID: 26965125 [TBL] [Abstract][Full Text] [Related]
11. Strength of activation and temporal dynamics of bioluminescent-optogenetics in response to systemic injections of the luciferin. Murphy EF; Means A; Li C; Baez H; Gomez-Ramirez M Neuroimage; 2024 Nov; 301():120882. PubMed ID: 39362505 [TBL] [Abstract][Full Text] [Related]
12. Improved trafficking and expression of luminopsins for more efficient optical and pharmacological control of neuronal activity. Zhang JY; Tung JK; Wang Z; Yu SP; Gross RE; Wei L; Berglund K J Neurosci Res; 2020 Mar; 98(3):481-490. PubMed ID: 31670406 [TBL] [Abstract][Full Text] [Related]